Feature | October 10, 2013

Penn Study Shows High Costs of Unnecessary Radiation Treatments for Terminal Cancer Patients

Single radiation treatment as effective as multiple radiation treatments

October 10, 2013 — Medical evidence over the past decade has demonstrated that patients with terminal cancer who receive a single session of radiotherapy get just as much pain relief as those who receive multiple treatments. But despite its obvious advantages for patient comfort and convenience (and cost savings), this single-fraction treatment has yet to be adopted in routine practice, according to a study led by the Perelman School of Medicine at the University of Pennsylvania published in The Journal of the American Medical Association (JAMA).

“Increased use of single fraction treatment would achieve the holy grail of health reform, which is real improvements in patient care at substantial cost savings,” said Justin Bekelman, M.D., assistant professor, Penn Medicine’s Abramson Cancer Center and lead author of the study. “Despite the evidence, single fraction treatment is used rarely and it’s reserved for patients with the poorest prognosis.”

Bekelman and his colleagues examined a group of 3,050 patients 65 years and older treated with radiotherapy for advanced prostate cancer and bone metastases. In the analysis of patients drawn from the national Surveillance, Epidemiology and End Results (SEER)-Medicare database, they found only 3 percent of patients studied received just single-fraction treatment, and nearly half the patients had more than 10 treatments. The costs of the excess treatments, the authors found, were substantial: mean 45-day radiotherapy-related expenditures were 62 percent lower for patients who received one treatment, at $1,873 for single versus $4,967 for multiple fractions.

Professional societies have recommended single-fraction treatment over multiple fractions for routine pain control except in cases with complications that require specialized therapy, such as spinal cord compression or broken bones caused by tumors.

Bekelman’s findings underscore the importance of efforts such as the Choosing Wisely campaign, which seeks to identify and promote medical practices that offer the highest value and best outcome for patients. Bekelman’s data shows that patients are routinely receiving extra radiation treatments that drive up health care costs without conferring additional benefits to patients.

“Whether you get more or less radiation for bone metastases has nothing to do with survival,” said Bekelman. “When clear and consistent evidence exists that supports single fraction treatment, we should proceed with the treatment that has equivalent pain control, is more convenient and gets patients out of treatment quicker.”

For more information: jama.jamanetwork.com, www.cancer.gov

Related Content

Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi